A PP2A-B55-Mediated Crosstalk between TORC1 and TORC2 Regulates the Differentiation Response in Fission Yeast

被引:31
|
作者
Martin, Ruth [1 ]
Portantier, Marina [1 ]
Chica, Nathalia [1 ]
Nyquist-Andersen, Mari [1 ]
Mata, Juan [2 ]
Lopez-Aviles, Sandra [1 ]
机构
[1] Univ Oslo, Biotechnol Ctr Oslo, Gaustadalleen 21, N-0349 Oslo, Norway
[2] Univ Cambridge, Dept Biochem, Bldg O,Downing Site, Cambridge CB2 1QW, England
基金
英国生物技术与生命科学研究理事会;
关键词
PROTEIN PHOSPHATASE 2A; SCHIZOSACCHAROMYCES-POMBE; SEXUAL DEVELOPMENT; CELL-CYCLE; NITROGEN STARVATION; NEGATIVE REGULATION; GREATWALL KINASE; GENE-EXPRESSION; RHEB GTPASE; COMPLEX;
D O I
10.1016/j.cub.2016.11.037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Extracellular cues regulate cell fate, and this is mainly achieved through the engagement of specific transcriptional programs. The TORC1 and TORC2 complexes mediate the integration of nutritional cues to cellular behavior, but their interplay is poorly understood. Here, we use fission yeast to investigate how phosphatase activity participates in this interplay during the switch from proliferation to sexual differentiation. We find that loss of PP2A-B55(Pabl) enhances the expression of differentiation-specific genes and leads to premature conjugation. pabl deletion brings about a transcriptional profile similar to TORC1 inactivation, and deletion of pabl overcomes the repression of differentiation genes in cells overexpressing TORC1. Importantly, we show that this effect is mediated by an increased TORC2-AKT (Gad8) signaling. Under nutrient-rich conditions, PP2A-B55(Pab1) dephosphorylates Gad8 Ser546, repressing its activity. Conversely, TORC1 inactivation upon starvation leads to the inactivation of PP2A-B55Pabl through the Greatwall-Endosulfin pathway. This results in the activation of Gad8 and the commitment to differentiation. Thus, PP2A-B55(Pab1) enables a crosstalk between the two TOR complexes that controls cell-fate decisions in response to nutrient availability.
引用
收藏
页码:175 / 188
页数:14
相关论文
共 50 条
  • [31] TOR complex 2 (TORC2) in Dictyostelium suppresses phagocytic nutrient capture independently of TORC1-mediated nutrient sensing
    Rosel, Daniel
    Khurana, Taruna
    Majithia, Amit
    Huang, Xiuli
    Bhandari, Ramanath
    Kimmel, Alan R.
    JOURNAL OF CELL SCIENCE, 2012, 125 (01) : 37 - 48
  • [32] Phase 1 Expansion Study of an Oral TORC1/TORC2 Inhibitor (CC-223) in Non-Pancreatic Neuroendocrine Tumors (NET)
    Wolin, Edward
    Mita, Monica
    Meyer, Tim
    Bendell, Johanna
    Mahipal, Amit
    Nemunaitis, John
    Munster, Pam
    Paz-Arez, Luis
    Hull, Wayne
    James, Angela
    Trowe, Torsten
    Swaminathan, Mahesh
    Wu, Xiaoling
    de Haan, Hans
    PANCREAS, 2015, 44 (02) : 362 - 362
  • [33] Phase 1 Expansion Study of an Oral TORC1/TORC2 Inhibitor (CC-223) in Non-Pancreatic Neuroendocrine Tumors (NET)
    Wolin, Edward
    Mita, Monica
    Meyer, Tim
    Bendell, Johanna
    Mahipal, Amit
    Nemunaitis, John
    Wong, Lilly
    Wu, Xiaoling
    Carmichael, James
    Chopra, Rajesh
    Hege, Kristen
    PANCREAS, 2014, 43 (03) : 508 - 508
  • [34] TORC1 and TORC2 coactivators are required for tax activation of the human T-cell leukemia virus type 1 long terminal repeats
    Siu, Yeung-Tung
    Chin, King-Tung
    Siu, Kam-Leung
    Choy, Elizabeth Yee Wai
    Jeang, Kuan-Teh
    Jin, Dong-Yan
    JOURNAL OF VIROLOGY, 2006, 80 (14) : 7052 - 7059
  • [35] Fission yeast TORC1 regulates phosphorylation of ribosomal S6 proteins in response to nutrients and its activity is inhibited by rapamycin
    Nakashima, Akio
    Sato, Tatsuhiro
    Tamanoi, Fuyuhiko
    JOURNAL OF CELL SCIENCE, 2010, 123 (05) : 777 - 786
  • [36] Casein kinase 1 controls components of a TORC2 signaling network in budding yeast
    Lucena, Rafael
    Jasani, Akshi
    Anastasia, Steph
    Kellogg, Douglas
    Alcaide-Gavilan, Maria
    JOURNAL OF CELL SCIENCE, 2024, 137 (24)
  • [37] Phase 1 Expansion Study of an Oral TORC1/TORC2 Kinase Inhibitor (CC-223) in Non-Pancreatic Neuroendocrine Tumors (NET)
    Meyer, T.
    Mahipal, A.
    Bendel, J.
    Nemunaitis, J.
    Mita, M.
    Wong, L.
    Wu, X.
    Chopra, R.
    Hege, K.
    Wolin, E.
    NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 276 - 276
  • [38] Protein kinase A regulates the Ras, Rap1 and TORC2 pathways in response to the chemoattractant cAMP in Dictyostelium
    Scavello, Margarethakay
    Petlick, Alexandra R.
    Ramesh, Ramya
    Thompson, Valery F.
    Lotfi, Pouya
    Charest, Pascale G.
    JOURNAL OF CELL SCIENCE, 2017, 130 (09) : 1545 - 1558
  • [39] Palomid 529, a Novel Small-Molecule Drug, Is a TORC1/TORC2 Inhibitor That Reduces Tumor Growth, Tumor Angiogenesis, and Vascular Permeability
    Xue, Qi
    Hopkins, Benjamin
    Perruzzi, Carole
    Udayakumar, Durga
    SherriS, David
    Benjamin, Laura E.
    CANCER RESEARCH, 2008, 68 (22) : 9551 - 9557
  • [40] Phase I expansion trial of an oral TORC1/TORC2 inhibitor (CC-223) in diffuse large B-cell lymphoma (DLBCL) and multiple myeloma (MM)
    Goy, Andre
    Ribrag, Vincent
    Varga, Andrea
    Witzig, Thomas E.
    Ocio, Enrique M.
    Paz-Ares, Luis G.
    Mita, Monica M.
    Meyer, Tim
    Munster, Pamela N.
    Mahipal, Amit
    Delord, Jean-Pierre
    Arkenau, Hendrik-Tobias
    Gutierrez, Martin
    James, Angela
    Wong, Lilly
    Xu, Shuichan
    Wu, Xiaoling
    Carmichael, James
    Chopra, Rajesh
    Hege, Kristen
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)